Sales decline 51.23% to Rs 2.98 crore
Net loss of Beryl Drugs reported to Rs 0.35 crore in the quarter ended March 2024 as against net profit of Rs 0.06 crore during the previous quarter ended March 2023. Sales declined 51.23% to Rs 2.98 crore in the quarter ended March 2024 as against Rs 6.11 crore during the previous quarter ended March 2023.For the full year,net profit remain constant at Rs 0.77 crore in the year ended March 2024 and also during the previous year ended March 2023. Sales declined 0.60% to Rs 26.73 crore in the year ended March 2024 as against Rs 26.89 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales2.986.11 -51 26.7326.89 -1 OPM %1.014.26 -9.998.26 - PBDT-0.100.20 PL 2.211.80 23 PBT-0.420.05 PL 1.010.99 2 NP-0.350.06 PL 0.770.77 0
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
